Suppr超能文献

肾小管分泌受抑制后基于血浆肌酐估算肾小球滤过率:肌酐检测的相关性

Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion: relevance of the creatinine assay.

作者信息

Kemperman F A, Silberbusch J, Slaats E H, van Zanten A P, Weber J A, Krediet R T, Arisz L

机构信息

Department of Internal Medicine, Hospital Onze Lieve Vrouwe Gasthuis, University of Amsterdam, The Netherlands.

出版信息

Nephrol Dial Transplant. 1999 May;14(5):1247-51. doi: 10.1093/ndt/14.5.1247.

Abstract

BACKGROUND

Estimation of glomerular filtration rate (GFR) from plasma creatinine concentration after inhibition of tubular creatinine secretion with cimetidine provides a good assessment in patients with various nephropathies and with non-insulin-dependent diabetes mellitus (NIDDM). The aim of this study was to compare cimetidine-aided GFR estimations using various creatinine assays.

METHODS

In 30 outpatients with NIDDM GFR was measured as the urinary clearance of continuously infused [125I]iothalamate. Plasma creatinine concentration was analysed after oral cimetidine with an alkaline picrate (AP) method, with an enzymatic (PAP) assay and with HPLC. GFR estimations were calculated with the Cockcroft Gault formula (CG).

RESULTS

AP creatinine concentrations were significantly higher than PAP or HPLC values. GFR estimations by AP (CG(AP) 66 +/- 19 ml/min/1.73 m2, mean SD) were significantly lower than GFR (89 +/- 30), whereas CG(PAP) (85 +/- 30) and CG(HPLC) (84 +/- 34 ml/min/1.73 m2) were not. Bland and Altman analysis showed a difference between CG(AP) and GFR of -22.4 +/- 17.7 ml/min/1.73 m2; this difference becomes larger when the GFR increases. The difference between CG and GFR was only -3.8 +/- 14.8 ml/min/1.73 m2 for PAP and -4.4 +/- 17.5 ml/min/1.73 m2 for HPLC, without any systematic difference.

CONCLUSION

A good assessment of the GFR from plasma creatinine after cimetidine administration is possible when creatinine is measured with an enzymatic assay or with the less convenient HPLC method. The more widespread and cheaper alkaline picrate assay is not suitable for GFR-estimation.

摘要

背景

使用西咪替丁抑制肾小管肌酐分泌后,根据血浆肌酐浓度估算肾小球滤过率(GFR),可为患有各种肾病和非胰岛素依赖型糖尿病(NIDDM)的患者提供良好的评估。本研究的目的是比较使用各种肌酐检测方法在西咪替丁辅助下的GFR估算值。

方法

对30例NIDDM门诊患者,通过连续输注[125I]碘肽酸盐的尿清除率来测量GFR。口服西咪替丁后,采用碱性苦味酸盐(AP)法、酶法(PAP)和高效液相色谱法(HPLC)分析血浆肌酐浓度。使用Cockcroft Gault公式(CG)计算GFR估算值。

结果

AP法测得的肌酐浓度显著高于PAP法或HPLC法测得的值。AP法估算的GFR(CG(AP) 66±19 ml/min/1.73 m2,均值±标准差)显著低于实际GFR(89±30),而CG(PAP)(85±30)和CG(HPLC)(84±34 ml/min/1.73 m2)则不然。Bland和Altman分析显示,CG(AP)与GFR之间的差异为-22.4±17.7 ml/min/1.73 m2;当GFR升高时,这种差异会变大。PAP法中CG与GFR之间的差异仅为-3.8±14.8 ml/min/1.73 m2,HPLC法中为-4.4±17.5 ml/min/1.73 m2,且无任何系统差异。

结论

当使用酶法或不太便捷的HPLC法测量肌酐时,服用西咪替丁后根据血浆肌酐对GFR进行良好评估是可行的。更广泛使用且成本较低的碱性苦味酸盐法不适用于GFR估算。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验